Should Women Be Able to Abort a Fetus Just Because It’s Female?
By Emma Green,
The Atlantic
| 05. 16. 2016
Over the past year, Indiana hasn’t exactly been a leader in anti-discrimination law. Last spring, the state faced massive protests and boycott threats for legislation that may have facilitated discrimination against lesbian, gay, bisexual, and transgender people. And this winter, nascent efforts to pass LGBT protections in hiring, housing, and public accommodations quickly failed.
But in March, the state did pass nearly unprecedented discrimination protections for one group: unborn fetuses. The new law prohibits abortions sought because of “race, color, national origin, ancestry, sex, or diagnosis or potential diagnosis of the fetus having Down syndrome or any other disability.” Doctors who perform them can be held liable in a lawsuit and sanctioned by Indiana’s medical boards.
Pro-life advocates celebrated the law’s passage. Indiana’s legislators wanted to make sure “ours is a policy that values life no matter who you are, where you come from or what your disability might be,” as the bill’s sponsor, Casey Cox, said.
But whether they intended to or not, these lawmakers exposed a set of difficult moral questions that pro-choice progressives tend to ignore in...
Related Articles
By Grace Won, KQED [with CGS' Katie Hasson] | 12.02.2025
In the U.S., it’s illegal to edit genes in human embryos with the intention of creating a genetically engineered baby. But according to the Wall Street Journal, Bay Area startups are focused on just that. It wouldn’t be the first...
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...
By Antonio Regalado, MIT Technology Review | 10.31.2025
A West Coast biotech entrepreneur says he’s secured $30 million to form a public-benefit company to study how to safely create genetically edited babies, marking the largest known investment into the taboo technology.
The new company, called Preventive, is...